JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landolt-Marticorena, C.
Right arrow Articles by Manolson, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landolt-Marticorena, C.
Right arrow Articles by Manolson, M. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 37, 26057-26064, September 10, 1999


Substrate- and Inhibitor-induced Conformational Changes in the Yeast V-ATPase Provide Evidence for Communication between the Catalytic and Proton-translocating Sectors*

Carolina Landolt-MarticorenaDagger , Walter H. KahrDagger , Paul ZawarinskiDagger , Judy CorreaDagger , and Morris F. ManolsonDagger §

From the Dagger  Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada and § Faculty of Dentistry, University of Toronto, Toronto, Ontario, M5G 1G6, Canada

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The vacuolar-type H+-ATPases (V-ATPases) are composed of two distinct sectors, a catalytic complex (V1) involved in ATP hydrolysis and a membrane-associated complex (V0) mediating proton translocation across a lipid bilayer. To date, little is known about the mechanism by which these two functions are coupled. We sought to examine the impact of nucleotide and cation binding on the structure of the core components of the catalytic complex and to determine whether conformational changes within the catalytic complex impact subunits of the membrane-associated complex. Nucleotide- and cation- induced changes in the catalytic core of the V-ATPase were investigated by monitoring changes in the rate and pattern of tryptic digests. ATP·Mg-induced changes were detected in both the catalytic (Vma1p or 69 kDa) and the regulatory subunits (Vma2p or 60 kDa) of the V1 sector. ATP alone increased the rate of trypsinization of the regulatory subunit, but did not have any effect on Vma1p. Surprisingly, ATP also had an impact on the 95-kDa subunit, a component of the V0 sector of the V-ATPase. Although the presence of divalent cations had no impact on the V1 sector, the rate of trypsinization of the 95-kDa subunit was greatly enhanced. The effect of divalent cations on the structure of the 95-kDa subunit was abrogated when trypsinization was performed in the absence of the catalytic sector. Addition of bafilomycin A1, a V-ATPase inhibitor that putatively binds to the 95-kDa subunit, increased the rate of trypsinization of the catalytic subunit. These data suggest that structural alterations within the V1 sector result in alterations within the V0 sector and vice versa. Clearly, a structural link must exist to couple the two sectors. The 95-kDa subunit is ideally suited to fulfill this role. Hydropathy analysis suggests a bipartite structure, with the NH2-terminal portion predicted to lie in an aqueous environment and the C-terminal portion predicted to contain 6 transmembrane segments. Tryptic digests of sealed vacuolar vesicles and immunofluorescence studies revealed that the large hydrophilic NH2-terminal domain of the 95-kDa subunit is localized toward the cytosol. This region therefore is ideally positioned to interact with components of the V1 complex, potentially functioning as the elusive link between the two sectors of the V-ATPase.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Vacuolar-type H+-ATPases (V-ATPases)1 are multimeric complexes that mediate the luminal acidification of various organelles (e.g. yeast and plant vacuoles, endosomes, lysosomes, phagosomes, and clathrin-coated vesicles) (for review, see Ref. 1). Organellar acidification is essential for a variety of cellular processes, including receptor-mediated endocytosis, processing and proteolysis of proteins, intracellular degradation of ingested pathogens and proton-coupled transport of small molecules. The V-ATPase complex contains two distinct structural sectors, a peripheral catalytic complex (V1) mediating ATP hydrolysis and a membrane-associated complex (V0) defining the proton channel proper (for review, see Ref. 1).

The soluble catalytic sector of the yeast V-ATPase consists of at least 8 subunits. The catalytic core is composed of a hexamer formed by alternating 69-kDa (Vma1p or A) and 60-kDa (Vma2p or B) subunits symmetrically arranged to generate a hollow core through the middle of the sphere. Vma1p and Vma2p both contain consensus sequences for ATP-binding domains; Vma1p has been ascribed a catalytic function, whereas Vma2p is thought to have a regulatory function. The hollow core formed by the ATP-binding subunits contains a central stalk, which is likely composed of the Vma4p, Vma7p, Vma8p, and Vma10p subunits (27, 14, 32, and 13 kDa, respectively) (2). The function of the V1 subunits Vma13p (54 kDa) and Vma5p (42 kDa) is not known.

The membrane-bound V0 complex is composed of at least 5 subunits. The proteolipid believed to form the proton channel (3) is encoded by three genes, VMA3 (17 kDa), VMA11 (17 kDa), and VMA16 (23 kDa) (4). The 100-kDa V0 subunit is encoded in yeast by VPH1 (5) and STV1 (6). Vph1p and Stv1p are functional homologues, but they are targeted to different organelles within the cell, suggesting that this subunit is involved in the differential regulation of V-ATPase activity. The function of the 36-kDa V0 subunit, Vma6p, is not known.

The V-type and the mitochondrial F-type ATPases share a common structural architecture. The F-type ATPases are also defined by a bipartite structure with a hydrophilic catalytic sector (F1) and a hydrophobic proton-conducting component (F0) (7). The crystal structure of the F1 ATPase sector shows the catalytic (beta ) and regulatory (alpha ) subunits arranged in an alternating hexagonal circular array, with the nucleotide binding sites localized to the beta -alpha interface (8). The catalytic binding sites are located in the beta -subunit with the noncatalytic sites restricted to the alpha -subunit. Because of the structural similarity between the ATPases, the catalytic and noncatalytic nucleotide binding sites in the V1 sector are likely to be similarly arranged.

Several lines of evidence substantiate that the A subunit of the V-ATPases contains the catalytic binding sites. The A subunit contains all the consensus loops, including a glycine-rich loop region (9) that was identified as critical for ATP hydrolysis in the beta -subunit of the F-ATPases. In addition, the inhibitors N-ethylmaleimide and 7-chloro-4-nitrobenz-2-oza-1,3-diazole label the A subunit by covalently modifying a critical cysteine residue in the ATP binding site (10, 11). Site-directed mutagenesis of a single cysteine residue within the glycine-rich loop yields a fully active protein resistant to both inhibitors (12, 13). Finally, photolabeling of the A subunit with 2-azido-[32P]ATP correlates directly with inhibition of ATPase activity (14).

Current experimental evidence suggests that the nucleotide binding sites within the B subunit are noncatalytic. Although modification with photoaffinity analogues (3-0-(4-benzoyl)benzoyl-ATP (15) and 2-azido-[32P]ATP (14) has demonstrated the presence of nucleotide binding sites within the B subunit, there is little evidence to suggest that these sites are catalytic in nature. The absence of a glycine-rich consensus sequence within the B subunit supports this conclusion.

The impact of nucleotide binding on the conformation of the V1 catalytic and regulatory subunits remains unclear. The available data is contradictory; some evidence suggests that ATP binding to the catalytic subunit does not induce a conformational change, as assayed by alterations in sensitivity to proteolytic degradation (16). Conversely, conditions optimal for ATP hydrolysis promote the dissociation of the peripheral sector from the membrane, suggesting that catalysis induces a conformational change within V1 that facilitates its release (17, 18). Site-directed mutagenesis of the yeast catalytic subunit demonstrated that loss of activity impaired removal of the peripheral complex by KNO3 (19). These data strongly suggest that the catalytic subunit alters its conformation in response to substrate binding and/or hydrolysis.

Dissociation of the V1V0 complex results in a loss of proton translocation and ATP hydrolysis, with complex reassociation restoring both activities (20, 21). The ability to reassociate into an active complex demonstrates that both sectors are functionally interdependent although remaining structurally independent in isolation. The structural independence of the two sectors has been demonstrated in vivo (22). Mutants lacking a single subunit of the enzyme yielded assembled cytosolic V1 sectors in the absence of a V0 subunit, and membrane-associated assembled V0 sectors in the absence of a V1 constituent (22). Despite their structural autonomy, physical coupling of the two sectors is essential for activity, suggesting that protein subunits of a given sector may be responsive to conformational changes within its functional counterparts. As physical interactions between the two sectors is an absolute requirement for function, a number of structural links must exist to allow for sector interaction. To date, no such link has been identified for V-ATPases. Here, we present evidence suggesting that Vph1p is part of the structural link.

The Vph1p subunit is unique to V-ATPases. Hydropathy analysis of Vph1p predicts two distinct structural domains, a hydrophilic NH2-terminal domain (~50 kDa) and a hydrophobic C-terminal domain (~50 kDa) that contains 6-8 putative membrane-spanning regions. Through the use of limited proteolysis of intact vacuolar membranes and immunoblotting, as well as immunofluorescence, we have unambiguously localized the NH2 terminus of Vph1p to the cytosol. The disposition of the NH2-terminal Vph1p domain toward the cytosolic space would permit physical interactions of Vph1p with protein subunits of the V1 sector. Because of its unique bipartite structure and its structural responsiveness to substrate binding, we propose that Vph1p is ideally suited to serve as a structural and functional link between the two sectors of the V-ATPase.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials and Strains-- Zymolyase was purchased from ICN Biochemicals and bafilomycin A1 from Kamiya Biomedical Company. The strains of Saccharomyces cerevisiase used were the protease-deficient BJ926 (Mata/alpha , trp1/+, +/his1, prc1-126/prc1-126, pep4-3/pep4-3, prb1-1122/prb1-1122, can1/can1, gal2/gal2), MM108 (Matalpha vma1Delta ::URA3, his4, ura3-52) bearing a disruption of the 69-kDa catalytic subunit (Vma1p), and MM53 (alpha  ura3-52 Delta vph1::LEU2), which bears a disruption of the 95-kDa V-ATPase subunit, Vph1p. The strain BJ1991 (Matalpha pep4-3, leu2, trp1, ura3-52, prbl-1122) was also used. The protease-deficient yeast strain PK22 (Mat alpha  pep4-3, vma2Delta 1, ura3-52, his4-519, ade6, gal2) that is disrupted for the 60-kDa regulatory subunit, Vma2p, was kindly supplied by Dr. Patricia M. Kane, State University of New York Health Science Center, Syracuse, NY. Wild type yeast cells were grown overnight in 1% yeast extract (Difco), 2% bacto-peptone (Difco), and 2% dextrose (YEPD medium). The Delta vma1 and Delta vma2 strains were grown in YEPD adjusted to pH 5.0 with HCl, because cells lacking vacuolar ATPase activity grow optimally in acidified medium (23).

Purification of Vacuolar Membranes-- Isolation of transport-competent vacuolar membrane vesicles through flotation of intact vacuoles on Ficoll gradients was performed as described in (5). Protein concentrations of vacuolar vesicles were measured by Lowry assays.

Proteolysis of Purified Vacuolar Membranes-- Purified vacuolar membranes were subjected to controlled trypsin proteolysis in the following manner: 20 µg of purified vacuolar membranes in 25 mM MES/Tris, pH 7.8, 25 mM KCl were incubated with varying concentrations of trypsin at 37 °C for 2 h. In addition, 5 mM of nucleotide (ATP, ADP, or ATPgamma S) and 5 mM divalent cation (MgCl2 or CaCl2) were included during proteolysis as indicated for each experiment. The final reaction volume was 100 µl. Trypsin proteolysis was inhibited by the addition of phenylmethylsulfonyl fluoride to a final concentration of 1 mM and tosyl-L-lysine chloromethyl ketone to a final concentration of 5 mM followed by incubation on ice for 15 min. Samples were denatured by the addition of 5× SDS sample buffer, assayed by SDS-PAGE (24), and immunoblotting as described by Olmsted (25).

Proteolytic digests performed in the presence of ADP or ADP·Mg were treated as described above with a final concentration of 5 mM ADP and 5 mM MgCl2. Samples prepared in the presence of bafilomycin A1 were preincubated for 10 min at room temperature. Bafilomycin A1 was prepared in Me2SO and added to a final concentration of 1 µM. Control samples were corrected for the addition of Me2SO.

Vacuolar Integrity-- The integrity of the purified vacuolar membranes to exogenously added proteases was assayed by the ability of protease K to cleave pro-carboxypeptidase Y (CPY) to its mature form in the absence and presence of detergent. Intact vacuoles purified from BJ1991 were resuspended at 0.5 µg/µl in 10 mM MES-Tris, pH 6.9, and 30 µg/ml protease K in the presence or absence of 0.5% (w/v) Triton X-100 for 0, 2, 10, and 20 min, respectively. Proteolytic digests were terminated at the designated times with the addition of phenylmethylsulfonyl fluoride to a final concentration of 22.2 mM followed immediately by protein precipitation with ice-cold 20% trichloroacetic acid. Protein pellets were washed in ice-cold acetone to remove residual acid and denatured for SDS-PAGE followed by immunoblotting with a monoclonal antibody to CPY, 10A5-B5 (Molecular Probes).

Raising of NH2 Terminus Vph1p Antibody and Affinity Purification-- The antigen for immunization of the rabbits was keyhole limpet hemocyanin-conjugated via a cysteine group to the nonadecapeptide (VSEL[E right-arrow G]ELG[K right-arrow L]VQFRDLNPDV) corresponding to residues 26 to 44 of the rat 116-kDa subunit, with bolded residues changed as indicated to correspond more closely with the yeast Vph1p sequence. Each rabbit was injected with 1 mg of peptide/carrier in Freund's complete adjuvant. At days 20, 38, 45, and 60 each rabbit was re-injected with 1 mg of labeled keyhole limpet hemocyanin in Freund's incomplete adjuvant. Rabbits were sacrificed at day 70. Serum was collected by incubating the rabbit's blood at 37 °C until coagulation, centrifuging the sample, and then collecting the supernatant. Immunoglobulins were precipitated from raw sera by 50% (NH4)2SO4, the pellet was resuspended to 50% of the original volume, and dialyzed overnight against 10 mM Tris-HCl, pH 7.3, 0.9% NaCl. Whole yeast homogenate prepared from a Delta vph1 mutant strain was prepared as described (6), electrophoresed, and transferred to nitrocellulose. The blot was incubated with blocking buffer routinely used for immunoblotting (25). The dialysate and blot were incubated for 1 h to absorb any anti-yeast immunoglobulins with the obvious exception of anti-Vph1p antibodies. Anti-NH2 terminus Vph1p antibodies were purified using the method described by Manolson et al. (5).

Antibodies-- ATPase subunits were detected with one of the following antibodies: 1) a rabbit polyclonal antibody raised against the catalytic 69-kDa V-ATPase A subunit purified from Beta Vulgaris L. (described in Ref. 26); 2) a rabbit polyclonal antibody directed against the regulatory 60-kDa B subunit of murine V-ATPase (described in Ref. 27); 3) a monoclonal antibody directed against the 60-kDa Vma2p subunit (clone 13D11-B2, Molecular Probes); 4) a rabbit polyclonal antibody directed against full-length Vph1p (described in Ref. 5); 5) a rabbit polyclonal antibody directed against the NH2 terminus of yeast Vph1p, as described above.

Immunofluorescence Microscopy-- Slides for immunofluorescence were prepared exactly as described by Manolson et al. (6) and were viewed with a Nikon epifluorescence Diaphot-TMD microscope. Images were photographically recorded on Kodak TMAX film with resulting pictures subsequently digitized. The primary antibodies used were as follows: rabbit affinity-purified anti-Vph1p was diluted 1:50, and rabbit affinity-purified anti-NH2 terminus Vph1p was diluted 1:25. The secondary antibody used was CY3 at a dilution of 1:1,000.

Assignment of Putative Transmembrane Segments for Vph1p-- Currently, 9 primary amino acid sequences, deduced from cDNA, are available for the 95-kDa subunit of V-ATPase; yeast Vph1p (M89778), yeast Stv1p (V06465), rat Vpp1 (M58758), mouse TJ6 (M31226), Neurospora crassa (3929395), Caenorhabditis elegans VPP1 (211115), human (Z711460), human osteoclast (U45285), and bovine (L31770). Because multiple sequence-based secondary structure predictions are substantially more accurate (28), the above sequences were aligned and used to identify putative transmembrane segments. These sequences were submitted to the PHD mail server described by Rost et al. (29). The data obtained from the PHD algorithm, coupled with topological data presented in this paper, were utilized to generate a topological folding model of Vph1p.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Limited Proteolysis of Vacuolar H+-ATPase Demonstrates That ATP·Mg Induces Conformational Changes in the Catalytic Subunit, Vma1p-- Physical coupling of the V1 and V0 subunits is a requirement for catalysis and proton translocation. Consequently, structural changes within one sector likely impact on the conformation of the other sector. Moreover, dissociation of V1 from V0 is enhanced in the presence of ATP·Mg, suggesting that substrate binding results in conformational changes within the V1 sector, allowing for its release. These issues were addressed by a careful analysis of conformational changes induced within subunits of both sectors, as assayed by limited trypsin proteolysis.

Analysis of conformational changes induced within the catalytic and regulatory subunits of the V-ATPase by nucleotide, cofactor, and inhibitor binding was undertaken. Limited tryptic digests of purified vacuolar membranes were performed in the presence of nucleotides (ATP or ADP) and/or magnesium. Proteolytic products were resolved by SDS-PAGE and visualized by immunoblotting with antibodies directed against the catalytic subunit, Vma1p (Fig. 1). As previously noted (16), ATP had no protective effect on the catalytic subunit. Also, neither ADP nor ADP·Mg had a protective effect on Vma1p (Fig. 1, panels B and C). In contrast, the rate of trypsinization of Vma1p was retarded in the presence of ATP·Mg (Fig. 1, panel E, lane 4). These results demonstrate that only the endogenous V-ATPase substrate can induce a conformational change in the catalytic subunit.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 1.   Protection of the catalytic V-ATPase subunit, Vma1p, from proteolytic degradation by ATP·Mg. Tryptic digests of purified vacuolar membranes were performed at 37 °C for 2 h in 25 mM MES/Tris, pH 7.8, 25 mM KCl and for panel B, 5 mM ADP; panel C, 5 mM ADP and 5 mM MgCl2; panel D, 5 mM ATP; and panel E, 5 mM ATP and 5 mM MgCl2. Final trypsin concentrations were 0.01, 0.05, 0.1, 0.5, 1.0, and 2.5 µg/ml, as indicated above the panels. Lanes 1-4 contain 2 µg of total vacuolar protein. Immunoblots were probed with a polyclonal antibody directed against the plant catalytic A subunit (26).

Limited Proteolysis of Vacuolar H+-ATPase Demonstrates That ATP·Mg Induces Conformational Changes in the Regulatory Subunit, Vma2p-- Photolabeling experiments have identified a nucleotide binding site on Vma2p, a putative regulatory subunit of the V-ATPase complex (14, 15, 30). A reconstituted recombinant subunit B can be labeled by radioactive nucleotides in a divalent cation (Mg2+ and Ca2+)-dependent manner (30). Previous studies have reported that ATP did not alter the pattern or rate of trypsinization of the B subunit (16). Given that ATP·Mg renders the catalytic subunit resistant to trypsin proteolysis and that ATP labeling of the B subunit is cation-dependent, experiments were undertaken to determine whether the presence of nucleotides and/or cations alter the proteolytic susceptibility of Vma2p.

Partially purified vacuolar membranes were treated with increasing concentrations of trypsin in the absence or presence of ATP. Proteolytic products were resolved by SDS-PAGE and assayed by immunoblotting (Fig. 2, panels A and B) with two different antibodies to identify the maximum number of trypsin-generated peptides. Vma2p was more sensitive than the catalytic subunit to proteolytic degradation under all conditions assayed, requiring the use of much lower trypsin concentrations (0.01 µg/ml to 0.25 µg/ml). Trypsin degradation of Vma2p was accelerated in the presence of ATP (Fig. 2, panels A and B, lanes 6-9) and further enhanced with ATP·Mg (Fig. 2, panels A and B, lanes 10-13). Particularly striking was the generation of a 30-kDa peptide in samples treated with 0.25 µg/ml trypsin in the presence of ATP·Mg (indicated by line). This peptide was not detected in samples treated with identical trypsin concentrations in the absence of nucleotide and cofactor. The 30-kDa peptide is not the result of a novel cleavage site unmasked by the presence of ATP·Mg, because an identical product was detected in samples treated with higher trypsin concentrations (>0.3 µg/ml) in the absence of nucleotide and/or magnesium. This result demonstrates increased proteolytic susceptibility of Vma2p in the presence of ATP·Mg. The question remains as to whether these nucleotide-mediated conformational effects are due to direct binding to Vma2p or a consequence of nucleotide binding to Vma1p. Efforts to restrict nucleotide binding (via photolabeling with azido-ATP) to Vma1p to determine whether labeling at the catalytic site was sufficient to render the Vma2p more proteolytically sensitive, proved inconclusive.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 2.   Increased proteolytic susceptibility of the regulatory V-ATPase subunit, Vma2p, in the presence of ATP and ATP·Mg. Tryptic digests of purified vacuolar membranes were performed at 37 °C for 2 h in 25 mM MES/Tris, pH 7.8, 25 mM KCl with the addition of 5 mM ATP for lanes 6-9 and 5 mM ATP and 5 mM MgCl2 for lanes 10-13. Final trypsin concentrations were 0.01, 0.05, 0.1, and 0.25 µg/ml, as indicated above the panels. All lanes contain 2 µg of purified total vacuolar proteins. Panel A, immunoblot was probed with a monoclonal antibody directed against the yeast regulatory subunit. Panel B, immunoblot was probed with polyclonal antibody directed against the rat regulatory B subunit (27). Arrowhead indicates size of full-length protein. A small proteolytic (30 kDa) generated in the presence of ATP·Mg is indicated by a line at the figure margin.

Limited Proteolysis of the Vacuolar H+-ATPase Reveals Distinct ATP and Mg2+-induced Conformational Changes in Vph1p, the 95-kDa Subunit of the V0 Sector-- Incubation of the V-ATPase complex with ATP·Mg leads to the dissociation of the V1 sector from the membrane-bound V0 sector (18). Preincubation of V-ATPases with N-ethylmaleimide at inhibiting concentrations prevents release of the V1 sector (11). This observation, coupled with data presented here, suggests that ATP·Mg binding induces a dramatic conformational change within Vma1p and Vma2p. This structural change, once transmitted to the remaining complex, allows for dissociation of the two sectors. Thus binding of ATP·Mg to the catalytic and regulatory subunits may induce a conformational change(s) in additional subunits within the V-ATPase complex. Of particular interest are conformational changes induced within the V0 complex, demonstrating a structural interdependence between the two sectors.

Our efforts focused on the 95-kDa subunit (Vph1p) for a number of reasons. Hydropathy analysis of Vph1p predicts a large hydrophilic amino-terminal domain and a hydrophobic C-terminal domain with 6-8 putative transmembrane segments (5). Although the topology of Vph1p has not been elucidated, proteolytic digests and labeling with impermeant reagents have demonstrated that regions of the protein are cytosolically exposed (31, 32). Because of its dual domain structure, the 95-kDa subunit is potentially available to interact with the V1 and V0 sectors (5). This hypothesis is supported by the finding that Vph1p is required for the proper assembly of V0 and the functional association of the two sectors (33). Because Vph1p appears to be required for the structural coupling of V1 and V0 complexes, it may be responsive to conformational changes occurring within the peripheral sector. To determine whether this was the case, the following experiments were performed. Under routine purification conditions, the 95-kDa subunit is rapidly cleaved to a ~ 80-kDa peptide product by endogenous vacuolar proteases. Isolation of vacuoles from pep4-3 strains, in which proteinase A-dependent proteases are inactive, yields only the full-length 95-kDa protein (5). All vacuoles used for tryptic digests were purified from protease-deficient strains to avoid confounding effects due to endogenous proteases. Tryptic digests of vacuolar membranes in the presence of either ATP or Mg2+ were performed, the trypsinized samples were resolved by SDS-PAGE, and assayed by immunoblotting with anti-Vph1p antibodies. Vph1p appears to undergo conformational changes in response to ATP and Mg2+. Samples digested in the presence of ATP were degraded less rapidly compared with controls (Fig. 3, ATP). Focusing on samples treated with 2.5 µg/ml trypsin (Fig. 3, lanes 7, 13, and 19), it is clear that production of the smallest peptide product (indicated by a line) decreases with inclusion of ATP and, surprisingly, increases when digests are performed in the presence of magnesium. These results suggest that the conformation of Vph1p is responsive to both ATP and magnesium.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 3.   Variable proteolytic susceptibility of the 95-kDa V-ATPase subunit, Vph1p, in the presence of ATP or magnesium. Tryptic digests of purified vacuolar membranes were performed at 37 °C for 2 h in 25 mM MES/Tris, pH 7.8, 25 mM KCl with the addition of 5 mM ATP (ATP) and 5 mM MgCl2 (Mg2+). Control shows samples digested in the absence of nucleotide or divalent cation. Final trypsin concentrations were 0.01, 0.05, 0.1, 0.5, 1.0, and 2.5 µg/ml, as indicated above the three panels. All lanes contain 2 µg of purified total vacuolar proteins. Immunoblots were probed with a polyclonal antibody directed against the yeast 95-kDa subunit. The arrow indicates size of full-length protein.

To date, no ATP or cation binding sites have been identified within the 95-kDa subunit (5). Ruthenium red binding has been successfully used to identify a number of cation binding proteins (34). No ruthenium red binding was detected for purified Vph1p (data not shown), confirming that Vph1p does not bind divalent cations. Thus, conformational changes induced by divalent cations or ATP must occur through their binding to other proteins within the V-ATPase complex. Clearly, the catalytic and regulatory subunits are likely candidates given that both bind nucleotides and divalent cations and undergo marked conformational perturbations upon binding. The data suggest that conformational changes induced by substrate binding to the V1 sector are transmitted to Vph1p. In this case, removal of the peripheral sector should render Vph1p insensitive to either nucleotide or divalent cations and the rate of proteolysis should be unaffected by the presence of either compound.

To test this model, membranes were purified from a protease-deficient yeast strain lacking a functional copy of the gene encoding the 60-kDa regulatory subunit of V-ATPase (Delta vma2). In the absence of Vma2p, the remaining peripheral subunits fail to associate with the vacuolar membrane (23, 35). V0 complexes in the Delta vma2 vacuolar membrane are functionally competent and reassemble with wild type V1 subunits, as assayed by restoration of ATPase activity (36) demonstrating that the isolated V0 complex adopts a native structure. Thus, membranes isolated from a Delta vma2 strain are a suitable source for isolated, intact, and fully assembled V0 sectors.

Although the isolated V0 sector was more susceptible to trypsin proteolysis than the intact complex, no difference in the rate of degradation was noted in the presence of ATP or magnesium (Fig. 4). The increased susceptibility to proteolytic degradation of the isolated V0 sector suggests that absence of V1 renders the membrane sector more accessible to the protease. This enhanced proteolytic sensitivity is consistent with previous reports that noted an increased rate of proteolysis for V0 sectors reconstituted in the absence of the peripheral sector (37). No novel proteolytic sites were detected, nor were tryptic sites lost in Vph1p. This suggests that the exposed regions of Vph1p do not undergo gross conformational changes in the absence of the V1 complex. The observation that Vph1p has become conformationally insensitive to ATP and divalent cations suggests that the subunit itself does not bind to either of these compounds. Rather, it is the binding of ATP and divalent cations to the V1 sector that transmits conformational changes to Vph1p.


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 4.   Absence of the peripheral sector abolishes the increased rate of proteolysis of Vph1p in the presence of magnesium. Vacuolar membranes were purified from a protease-deficient yeast strain lacking a functional copy of the gene encoding the 60-kDa regulatory subunit of V-ATPase (Delta vma2). V0 complexes in the Delta vma2 vacuolar membrane are functionally competent for reassembly with wild type V1 subunits, as assayed by restoration of ATPase activity (36). Tryptic digests of purified vacuolar membranes were performed at 37 °C for 2 h in 25 mM MES/Tris, pH 7.8, 25 mM KCl with the addition of 5 mM MgCl2 for the lower panel. The upper panel shows samples digested in the absence of nucleotide or divalent cation. Final trypsin concentrations were 0.01, 0.05, 0.1, 0.5, 1.0, and 2.5 µg/ml, as indicated above the panels. All lanes contain 2 µg of purified total vacuolar proteins. The middle and lower panels show samples digested under identical conditions with the exception that 5 mM MgCl2 (Mg2+) or 5 mM ATP (ATP) was added. Both immunoblots were probed with a polyclonal antibody directed against the yeast 95-kDa subunit. The arrow indicates size of full-length protein.

Binding of Bafilomycin A1, an Inhibitor of V-ATPase Activity, Induces Conformational Changes in the Vma1p Subunit-- Bafilomycin A1, a potent microlide inhibitor of vacuolar-type ATPases, binds to the membrane-associated sector (V0) of the complex (3, 38, 39). Specifically, it appears that the inhibitor binding site is contained within Vph1p. To determine whether bafilomycin A1 binding has an effect on the structure of Vph1p, partially purified vacuolar membranes were trypsinized in the presence of inhibitor. In addition to bafilomycin A1, digests were performed in the presence and absence of ATP and/or magnesium. Vacuolar membranes were preincubated with bafilomycin A1 for 10 min to ensure that inhibitor binding was not prevented by nucleotides or divalent cations. Samples were trypsinized, as described previously, and the generated peptides resolved by SDS-PAGE and assayed by immunoblotting. The presence of bafilomycin A1 did not alter the rate of proteolytic degradation of Vph1p (data not shown). This result may indicate that inhibitor binding to Vph1p does not cause a structural change within Vph1p. Alternatively, inhibitor binding may occur within the hydrophobic region of Vph1p and thus any conformational changes would not be detected by the use of antibodies targeted to hydrophilic surface epitopes.

Bafilomycin A1 alone or in the presence of nucleotide and cofactor rendered Vma1p more susceptible to proteolytic degradation (Fig. 5). This unexpected result indicates that binding of bafilomycin A1 to Vph1p induces a conformational change in the catalytic subunit of the V-ATPase. Surprisingly, samples trypsinized in the presence of ATP and bafilomycin A1 were most susceptible to proteolytic degradation (Fig. 5, lanes 5-7). Similar treatment in the presence of ATP·Mg was noted to minimize the effect of bafilomycin A1 on the proteolytic susceptibility of Vma1p (Fig. 5, lanes 8-10). These data suggest that a reciprocal structural relationship exists between the peripheral and membrane-associated sectors of the V-ATPase. As inhibitor binding to V0 induces a conformational change in the catalytic subunit of V1, cation binding to the peripheral sector induces a structural alteration in the membrane-bound complex.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   The catalytic V-ATPase subunit, Vma1p, is more susceptible to proteolysis in the presence of bafilomycin A1. Tryptic digests of purified vacuolar membranes were performed at 37 °C for 2 h in 25 mM MES/Tris, pH 7.8, 25 mM KCl with the addition of 5 mM ATP for lanes 5-7 and 5 mM ATP and 5 mM MgCl2 for lanes 8-10. Samples treated in the presence of inhibitor contained bafilomycin A1 to a final concentration of 1 mM. Final trypsin concentrations were 0.1, 1.0, and 2.5 µg/ml, as indicated above the panels. All lanes contain 2 µg of purified total vacuolar proteins. Immunoblots were probed with a polyclonal antibody directed against the plant catalytic subunit (26).

Localization of the NH2 Terminus of Vph1p to the Cytosol-- Results presented here indicate that Vph1p is responsive to conformational changes that originate within the peripheral sector (ATP·Mg binding to V1 sector) and conversely, that structural changes occurring within the 95-kDa subunit (bafilomycin A1 binding to Vph1p) can impact on the structure of the V1 sector. Clearly, the 95-kDa subunit must establish extensive protein-protein interactions to mediate such a degree of intersector communication. Current topological models of Vph1p (40) localize the extensive hydrophilic amino terminus to the vacuolar lumen. If disposed toward the cytosol, this large region of Vph1p would be an ideal candidate to serve as the structural link between the membrane-associated and the peripheral sectors.

The cellular location of the NH2 terminus of Vph1p was established by the following experiments. An antibody directed against the NH2 terminus of yeast Vph1p was raised in rabbits and affinity purified as detailed under "Experimental Procedures." Intact purified vacuolar membranes were trypsinized and proteolytic products were assayed by immunoblotting. Proteolytic cleavage at low trypsin concentrations (0.1 µg/ml) generated a single peptide product of approximately 90 kDa in size (Fig. 6, panel A), indicating the loss of either the N or C terminus of Vph1p. The failure of an antibody directed against the extreme NH2 terminus of yeast Vph1p to recognize the 90-kDa product peptide demonstrates that this fragment does not contain this region of the protein (Fig. 6, panel A). This result suggests that the NH2 terminus of Vph1p is disposed toward the cytosol.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 6.   The NH2 terminus of Vph1p is localized to the cytosol. Panel A, tryptic digests of intact vacuolar membranes were performed at 37 °C for 2 h in 25 mM MES/Tris, pH 7.8, 25 mM KCl with a final trypsin concentration of 0.01 µg/ml for lane 2 and 1.0 µg/ml for lane 3. All lanes contain 5 µg of purified vacuolar membrane proteins. The upper panel was probed with a polyclonal antibody directed against the full-length Vph1p. The lower panel was probed with a polyclonal antibody directed against the extreme NH2 terminus of yeast Vph1p. The full-length protein is indicated by a line at the left margin. Panel B, the integrity of the purified vacuolar membranes to exogenously added proteases was assayed by the ability of protease K to cleave pro-CPY (pCPY)to its mature form in the absence and presence of detergent. Pro-CPY and its mature form are normally sequestered in the vacuolar lumen. Intact vacuoles were treated with protease K (final concentration, 30 µg/ml) in the presence or absence of 0.5% (w/v) Triton X-100 for 0, 2, 10, and 20 min, respectively. Following trichloroacetic acid precipitation, the protein pellets were denatured and resolved by SDS-PAGE. Both immunoblots shown were probed with a commercially available monoclonal antibody to CPY. The full-length pro-protein (66 kDa) is indicated by a line at the left margin, whereas the processed form of carboxypeptidase Y is indicated by an arrow. Panel C, wild type (WT) and Delta vma1p, a Vma1p disruption mutant, were grown on complete medium as required. The cells were fixed, spheroplasted, permeabilized, and mounted onto slides as detailed under "Experimental Procedures." Cells were labeled with rabbit anti-full-length Vph1p (alpha -Vph1p) or rabbit anti-NH2 terminus Vph1p (alpha -NH2 terminus Vph1p) followed by CY3 conjugated goat anti-rabbit IgG. Identical fields are shown as viewed under Nomarski optics (Nomarski) and CY3 fluorescence optics (Fluorescence).

Accurate interpretation of these results requires confirmation of the membrane integrity of the purified vacuoles. Access to the vacuolar lumen would allow for the proteolytic cleavage of an NH2 terminus disposed toward the luminal space. To confirm the integrity of the vacuolar membrane, purified vacuoles, containing the luminally sequestered pro-form of carboxypeptidase Y (pro-CPY), were subjected to proteinase K digestion in the presence and absence of detergent (Triton X-100). Conversion of the pro-form of the enzyme to the mature form (CPY) was utilized as a marker for access by the protease to the vacuolar lumen. Samples were treated with (30 µg/ml) proteinase K for 0, 2, 10, or 20 min. Pro-CPY was only converted to the mature enzyme form in the presence of detergent (Fig. 6, panel B). Incubation of the purified vacuolar membranes with proteinase K for up to 20 min failed to generate cleaved CPY in the absence of detergent. Clearly, purified vacuolar membranes are sealed and able to exclude proteases from the luminal interior.

The cellular location of the NH2 terminus of Vph1p was confirmed by the use of immunofluorescence. A wild type yeast strain (BJ926) and a Delta vma1 strain (MM108) containing only assembled V0 complexes were used. The cells were fixed, spheroplasted, permeabilized, and mounted onto slides as described under "Experimental Procedures." As has been previously reported (41), vacuolar morphology of the wild type and mutant strains are indistinguishable under Nomarski optics (Fig. 6, panel C). The vacuolar membranes of the wild type and Delta vma1 strain showed comparable staining with an antibody directed against full-length Vph1p, which indicates that there are similar levels of expression and localization between the two yeast strains of the 95-kDa subunit. Differences were seen when the membranes were stained with the antibody directed against the NH2 terminus of Vph1p. Wild type vacuolar membranes showed minimal staining, whereas the Delta vma1 strain showed levels of vacuolar staining comparable with that obtained with the antibody directed against the full-length protein. The presence of the V1 subunit inhibits binding of the anti-NH2 terminus Vph1p antibody. This indicates that the NH2 terminus is localized to the cytosol and that it interacts with the V1 to the extent that the peripheral sector can block antibody binding. The topology of the C terminus has not been resolved, yet sequence analysis predicts at least 6-8 regions of sufficient length and hydrophobicity to function as membrane-spanning domains (5). To more accurately predict transmembrane segments, multiple sequence-based secondary structure predictions (as described in Ref. 29) were performed on the nine known protein sequences encoding the 95/116-kDa V0 subunit. The data obtained from the PDH algorithm, coupled with the topological data presented in this paper, were used to generate the topological folding model presented in Fig. 7.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 7.   Topological folding model of yeast Vph1p. The membrane domain of yeast Vph1p (residue 461-844) is proposed to span the membrane bilayer 6-8 times. Transmembrane segments were identified using the PHD algorithm. The hydrophilic NH2 terminus (residues 1-460) is localized toward the cytosol. Transmembrane segments are labeled TM 1-8. No experimental data is currently available on the topology of the transmembrane domain. The algorithm employed predicts a minimum of 6 transmembrane segments with a possible 8 membrane-spanning regions in the C terminus of Vph1p. Residues indicating the limits of the TM segments are indicated on the figure. Hatched TM segments were difficult to assign with certainty. In particular, TM7 and TM8 represent a long hydrophobic stretch (~30 residues) that could exist as a single TM domain or as two shorter TM segments.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The vacuolar ATPase is composed of two structural sectors (V1 and V0) that perform distinct functions, ATP hydrolysis and proton translocation. The sectors are functionally coupled with complex dissociation rendering both inactive. As demonstrated by this work, this is a dynamic relationship with substrate or inhibitor binding to one sector inducing conformational alterations within both complexes. The study was initiated by examining the impact of substrate binding on subunits (Vma1p and Vma2p) of the catalytic sector.

Nucleotide-induced conformational changes within the catalytic and regulatory subunits of the V-ATPase were monitored by alterations in susceptibility to trypsin proteolysis. Our results concur with previously published data that ATP alone has no protective effect on the catalytic subunit (16). Similarly, the binding of ADP or ADP·Mg did not protect Vma1p from proteolytic degradation, suggesting that occupancy of the catalytic site by ADP·Mg does not dramatically alter the conformation of Vma1p. Conversely, ATP·Mg does induce a conformational change within the catalytic subunit as demonstrated by its increased resistance to proteolytic degradation. To determine whether ATP hydrolysis, rather than ATP binding, was required to induce the observed conformational change, purified vacuolar membranes were trypsinized in the presence of ATPgamma S, a nonhydrolyzable ATP analogue. Trypsinization in the presence of ATPgamma S generated a proteolytic pattern indistinguishable from that obtained with hydrolyzable nucleotide (data not shown) under all conditions assayed (with or without Mg2+). Although the experimental conditions used allow for single site hydrolysis, it is clear that multisite catalysis is not required to induce a conformational change in the catalytic subunit.

The proteolytic susceptibility of Vma2p was increased in the presence of ATP and further enhanced in the presence of ATP·Mg. Clearly, substrate binding dramatically alters the conformation of the regulatory subunit. It remains unclear if this effect is due to ATP·Mg binding at the catalytic site, although this suggestion is indirectly supported by several lines of evidence. High resolution structural analysis of the F-ATPase peripheral sector suggests that Vma1p and Vma2p come together to form a catalytic site that resides primarily on Vma1p with some residues contributed by Vma2p (14, 42). Because the catalytic site is essentially shared by the two subunits, it is likely that binding of ATP·Mg alters both conformations. This presumption is supported by studies of in vitro reconstitution of the core V1 sector (subunits Vma1p, Vma2p, Vma4p, Vma7p, Vma8p, and Vma10p) showing that complex assembly is nucleated by the association of Vma1p and Vma2p with ATP·Mg stabilizing this critical interaction (2). These data suggest that binding of ATP·Mg likely induces a conformational change within Vma1p and/or Vma2p, providing a stable core for the formation of higher order complexes of the peripheral sector.

Compelling evidence indicates that ATP·Mg binding to the catalytic subunit induces a global conformational change within the peripheral sector, resulting in the dissociation of the soluble sector from the membrane-associated complex. It has been proposed that "chaotropic" anions mediate H+-ATPase inhibition by oxidizing critical sulfhydryl residues, which in turn leads to the release of the peripheral sector. Indeed, oxidation of these sites in the Neurospora V-ATPase is associated with the rapid dissociation of the V1 peripheral sector (43). In our hands, although chaotropic agents (KI) enhanced removal of the peripheral sector, ATP·Mg alone was sufficient to promote stripping of the V1 sector (data not shown). This ATP·Mg-induced peripheral sector dissociation is inhibited by N-ethylmaleimide modification of Vma1p. Clearly, substrate binding induces a global conformational change within the peripheral sector, allowing its release from the membrane-associated complex. Dissociation was neither inhibited or reduced in the presence of bafilomycin A1 or DCCD, potent inhibitors of V-ATPase activity, suggesting that multisite hydrolysis is not required to release the soluble V1 sector.

Of greater significance is the structural impact of substrate binding (ATP and/or divalent cations) on the conformation of components of the membrane-associated sector. Modification of the peripheral sector by ATP or divalent cations resulted in a conformational change within Vph1p, indicating that structural changes within the V1 sector impact on V0 components. There was a dramatic increase in the rate of Vph1p proteolysis in the presence of divalent cations (Mg2+, Ca2+, Mn2+) supporting the conclusion that a degree of intersector communication exists within V-ATPases. Particularly intriguing is the importance of divalent cations in maintaining the quaternary structure of the peripheral domain. Reconstitution experiments involving the isolated subunits of the hydrophilic sector demonstrated that assembly of the core was enhanced in the presence of divalent cations (2). Mg2+, Ca2+, and Mn2+ were found to be equally effective mirroring the pattern noted to increase the proteolytic susceptibility of Vph1p. These results suggest that cation binding induces a global conformational change that promotes formation of a stable peripheral complex. Moreover, this cation-induced conformational change is transmitted to the membrane-associated sector, as evidenced by the increased proteolytic susceptibility of Vph1p. The presence of cations did not enhance the rate of Vph1p proteolysis within isolated V0 sectors, providing compelling evidence that structural changes within Vph1p are mediated via intersector communication versus direct cation binding to the membrane-associated complex.

Data presented in this paper suggest that intersector communication is bidirectional, with conformational changes initiated within the membrane-associated sector reflected in a structural perturbation within the peripheral sector and vice versa. The V-ATPase inhibitor, bafilomycin A1, is known to bind to the V0 complex, with evidence suggesting that its binding site resides within Vph1p (3). Addition of bafilomycin A1 accelerated the rate of proteolysis of the catalytic subunit indicating that inhibitor binding to the hydrophobic sector results in a conformational change within Vma1p. Chromaffin granule V-ATPases show simple Michaelis-Menten kinetics with three apparent Km values (38). Addition of bafilomycin A1 impairs ATP hydrolysis and catalytic cooperativity, although hydrolysis at a single catalytic site remains resistant to the inhibitor (38). This suggests that binding of bafilomycin A1 to the hydrophobic sector impacts on the structure and function of the hydrophilic sector, particularly the catalytic subunit. A similar transmission of an inhibitory signal from the hydrophobic to hydrophilic sector has been observed in the inhibition of F0F1 ATPase by oligomycin and dicyclohexylcarbodiimide (44). Thus, intersector communication is reciprocal with conformational changes initiated within one sector reflected in compensatory structural changes within the opposing complex.

The specific structural link(s) that mediates this intersector communication remains unknown. Our work provides evidence that Vph1p might play a central role in coupling the two sectors of the V-ATPase with dynamic structural information readily transmitted between the V0 and V1 sectors. Because of its bipartite structure, Vph1p is an ideal candidate to serve as a functional and structural link between the catalytic and proton-translocating sectors of the V-ATPase. We have unambiguously localized the ~50-kDa hydrophilic NH2 terminus of Vph1p to the cytosol, where it is available to interact with the peripheral sector. Because of its localization to the vacuolar membrane, the C-terminal domain of Vph1p is in close proximity to the proton-translocating core of the V-ATPase, thus allowing for catalytically induced conformational changes within the peripheral sector to impact on the functioning of the ion channel. This model is supported by previous work demonstrating that mutagenesis of key residues within the membrane-associated domain of Vph1p inhibits both proton-translocation and ATPase activity (40, 45). This data indicates that the C terminus of Vph1p is essential for H+ translocation and that changes to this region impacts on the function of the catalytic sector. Thus, structural changes in the membrane domain of Vph1p are capable of transmitting an inhibitory signal to the catalytic sector, supporting that Vph1p mediates intersector communication.

Recent work on the structurally related F-type ATPases has revealed a possible structural link between the F1 and F0 sectors (8). The 2.8 Å resolution structure of the soluble F1 complex shows that a central stalk connects the soluble and membrane-associated components of the F-type ATPase. The beta - and alpha -subunits are arranged in an alternating hexagonal array with the central pore of the structure occupied by two long alpha  helices contributed by the gamma -subunit. ATP hydrolysis drives the physical rotation of the central gamma  subunit (46, 47) that, in turn, drives proton translocation. Efficient transduction of the torque exerted by the rotating stalk on F0 requires the presence of a stator (48, 49), which prevents loss of energy through the rotation of F1 relative to F0. Subunits a, (b)2, and gamma  are likely candidates to fulfill this role in the F-type ATPases (50). To date, no corresponding subunits have been identified in the V-type ATPases, although a similar functional mechanism has been hypothesized. Because of its unique bipartite structure and its responsiveness to substrate binding, we propose that Vph1p is ideally suited to serve as the structural and functional link between the two sectors of the V-ATPase and suggest that it is part of the V-ATPase stator. Currently, work is underway to identify regions of interaction between the hydrophilic sector of Vph1p and components of the catalytic sector.

    ACKNOWLEDGEMENTS

We thank Patricia M. Kane and Kelly Williams for critical review of the manuscript. M. F. M also thanks Petra Kuehl for moral support and patience.

    FOOTNOTES

* This work was supported by a Medical Research Council of Canada operating grant (MT12053) and scholarship (to M. F. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Faculty of Dentistry Research Institute, 124 Edward St., Rm. 429, Dept. of Dentistry, University of Toronto, Toronto, Ontario M5G 1G6, Canada. Tel.: 416-979-4900 (ext. 4392); Fax: 416-979-4936; E-mail: m.manolson@utoronto.ca.

    ABBREVIATIONS

The abbreviations used are: V-ATPase, vacuolar-type proton-translocating adenosine triphosphatase; DCCD, N,N'-dicyclohexylcarbodiimide; PAGE, polyacrylamide gel electrophoresis; ATPgamma S, adenosine 5'-O-(thiotriphosphate); MES, 4-morpholineethanesulfonic acid; CPY, carboxypeptidase Y; TM, transmembrane.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Stevens, T. H., and Forgac, M. (1997) Annu. Rev. Cell Dev. Biol. 13, 779-808[CrossRef][Medline] [Order article via Infotrieve]
2. Tomashek, J. J., Graham, L. A., Hutchins, M. U., Stevens, T. H., and Klionsky, D. J. (1997) J. Biol. Chem. 272, 26787-26793[Abstract/Free Full Text]
3. Zhang, J., Feng, Y., and Forgac, M. (1994) J. Biol. Chem. 269, 23518-23523[Abstract/Free Full Text]
4. Hirata, R., Graham, L. A., Taktsuki, A., Stevens, T. H., and Anraku, Y. (1997) J. Biol. Chem. 272, 4795-4803[Abstract/Free Full Text]
5. Manolson, M. F., Proteau, D., Preston, R. A., Stenbit, A., Roberts, B. T., Hoyt, M. A., Preuss, D., Mulholland, J., Botstein, D., and Jones, E. W. (1992) J. Biol. Chem. 267, 14294-14303[Abstract/Free Full Text]
6. Manolson, M. F., Wu, B., Proteau, D., Taillon, B. E., Roberts, B. T., Hoyt, M. A., and Jones, E. W. (1994) J. Biol. Chem. 269, 14064-14074[Abstract/Free Full Text]
7. Bowman, B. J., and Bowman, E. J. (1996) in The Mycota III. Biochemistry and Molecular Biology (Brambl, R. , and Marzluf, G. A., eds), Vol. III , pp. 57-83, Springer-Verlag, Berlin
8. Abrahams, J. P., Leslie, A. G., Lutter, R., and Walker, J. E. (1994) Nature 370, 621-628[CrossRef][Medline] [Order article via Infotrieve]
9. Hirata, R., Ohsumk, Y., Nakano, A., Kawasaki, H., Suzuki, K., and Anraku, Y. (1990) J. Biol. Chem. 265, 6726-6733[Abstract/Free Full Text]
10. Feng, Y., and Forgac, M. (1992) J. Biol. Chem. 267, 5817-5822[Abstract/Free Full Text]
11. Feng, Y., and Forgac, M. (1994) J. Biol. Chem. 269, 13224-13230[Abstract/Free Full Text]
12. Taiz, L., Nelson, H., Maggert, K., Morgan, L., Yatabe, B., Taiz, S. L., Rubinstein, B., and Nelson, N. (1994) Biochim. Biophys. Acta 1194, 329-334[Medline] [Order article via Infotrieve]
13. Liu, Q., Leng, X. H., Newman, P. R., Vasilyeva, E., Kane, P. M., and Forgac, M. (1997) J. Biol. Chem. 272, 11750-11756[Abstract/Free Full Text]
14. Zhang, J., Vasilyeva, E., Feng, Y., and Forgac, M. (1995) J. Biol. Chem. 270, 15494-15500[Abstract/Free Full Text]
15. Manolson, M. F., Rea, P. A., and Poole, R. J. (1985) J. Biol. Chem. 260, 12273-12279[Abstract/Free Full Text]
16. Adachi, I., Arai, H., Pimental, R., and Forgac, M. (1990) J. Biol. Chem. 265, 960-966[Abstract/Free Full Text]
17. Kane, P. M., Yamashiro, C. T., and Stevens, T. H. (1989) J. Biol. Chem. 264, 19236-19244[Abstract/Free Full Text]
18. Moriyama, Y., and Nelson, N. (1989) J. Biol. Chem. 264, 3577-3582[Abstract/Free Full Text]
19. Liu, J., and Kane, P. M. (1996) Biochemistry 35, 10938-10948[CrossRef][Medline] [Order article via Infotrieve]
20. Kane, P. M. (1995) J. Biol. Chem. 270, 17025-17032[Abstract/Free Full Text]
21. Sumner, J. P., Dow, J. A., Earley, F. G., Klein, U., Jager, D., and Wieczorek, H. (1995) J. Biol. Chem. 270, 5649-5653[Abstract/Free Full Text]
22. Doherty, R. D., and Kane, P. M. (1993) J. Biol. Chem. 268, 16845-16851[Abstract/Free Full Text]
23. Noumi, T., Beltran, C., Nelson, H., and Nelson, N. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1938-1942[Abstract/Free Full Text]
24. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
25. Olmsted, J. B. (1981) J. Biol. Chem. 256, 11955-11957[Abstract/Free Full Text]
26. Manolson, M. F., Percy, J. M., Apps, D. K., Xie, X.-S., Stone, D. K., Harrison, M., Clarke, D. J., and Poole, R. J. (1989) Biochem. Cell Biol. 67, 306-310
27. Brisseau, G. F., Grinstein, S., Hackam, D. J., Nordstrom, T., Manolson, M. F., Khine, A. A., and Rotstein, O. D. (1996) J. Biol. Chem. 271, 2005-2011[Abstract/Free Full Text]
28. Rost, B., and Sander, C. (1993) J. Mol. Biol. 232, 584-599[CrossRef][Medline] [Order article via Infotrieve]
29. Rost, B., Sander, C., and Schneider, R. (1994) Comput. Appl. Biosci. 10, 53-60[Abstract/Free Full Text]
30. Peng, S. B. (1995) J. Biol. Chem. 270, 16926-16931[Abstract/Free Full Text]
31. Adachi, I., Puopolo, K., Marquez-Sterling, N., Arai, H., and Forgac, M. (1990) J. Biol. Chem. 265, 967-973[Abstract/Free Full Text]
32. Arai, H., Terres, G., Pink, S., and Forgac, M. (1988) J. Biol. Chem. 263, 8796-8802[Abstract/Free Full Text]
33. Kane, P. M. (1992) J. Exp. Biol. 172, 93-103[Abstract/Free Full Text]
34. Charuk, J. H. M., Pirraglia, C. A., and Reithmeier, R. A. F. (1990) Anal. Biochem. 188, 123-131[CrossRef][Medline] [Order article via Infotrieve]
35. Yamashiro, C. T., Kane, P. M., Wolczyk, D. F., Preston, R. A., and Stevens, T. H. (1990) Mol. Cell. Biol. 10, 3737-3749[Abstract/Free Full Text]
36. Parra, K. J., and Kane, P. M. (1996) J. Biol. Chem. 271, 19592-19598[Abstract/Free Full Text]
37. Zhang, J., Myers, M., and Forgac, M. (1992) J. Biol. Chem. 267, 9773-9778[Abstract/Free Full Text]
38. Hanada, H., Moriyama, Y., Maeda, M., and Futai, M. (1990) Biochem. Biophy. Res. Commun. 170, 873-878[CrossRef][Medline] [Order article via Infotrieve]
39. Crider, B. P., Xie, X. S., and Stone, D. K. (1994) J. Biol. Chem. 269, 17379-17381[Abstract/Free Full Text]
40. Leng, X. H., Manolson, M. F., Liu, Q., and Forgac, M. (1996) J. Biol. Chem. 271, 22487-22493[Abstract/Free Full Text]
41. Kane, P. M., Kuehn, M. C., Howald-Stevenson, I., and Stevens, T. H. (1992) J. Biol. Chem. 267, 447-454[Abstract/Free Full Text]
42. Arai, H., Berne, M., Terres, G., Terres, H., Puopolo, K., and Forgac, M. (1987) Biochemistry 26, 6632-6638[CrossRef][Medline] [Order article via Infotrieve]
43. Dschida, W. J., and Bowman, B. J. (1995) J. Biol. Chem. 270, 1557-1563[Abstract/Free Full Text]
44. Futai, M., Noumi, T., and Maeda, M. (1989) Annu. Rev. Biochem. 58, 111-136[CrossRef][Medline] [Order article via Infotrieve]
45. Leng, X. H., Manolson, M. F., and Forgac, M. (1998) J. Biol. Chem. 273, 6717-6723[Abstract/Free Full Text]
46. Noji, H., Yasuda, R., Yoshida, M., and Kinosita, K., Jr. (1997) Nature 386, 299-302[CrossRef][Medline] [Order article via Infotrieve]
47. Sabbert, D., Engelbrecht, S., and Junge, W. (1996) Nature